Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horacio Plotkin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Case Reports in Neurological Medicine|June 2, 2017
Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKANYiolanda-Panayiota Christou, George A Tanteles, Elena Kkolou, et al.
Southern Medical Journal|June 27, 2008
Special report on the 2007 Pediatric Position Development Conference of the International Society for Clinical DensitometryCatherine M Gordon, Sanford Baim, Maria-Luisa Bianchi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 14, 2009
The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophyRichard C Henderson, Lisa M Berglund, Ryan May, et al.
Bone|December 28, 2020
Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type VMichael P Whyte, James Aronson, William H McAlister, et al.
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
Molecular Genetics and Metabolism|June 18, 2021
Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?Anna Čechová, Tomáš Honzík, Andrew C Edmondson, et al.
Lancet (London, England)|August 10, 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trialNick Bishop, Silvano Adami, S Faisal Ahmed, et al.
Human Mutation|April 14, 2025
Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDGSander Pajusalu, Mari-Anne Vals, Mercedes Serrano, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Case Reports in Neurological Medicine|June 2, 2017
Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKANYiolanda-Panayiota Christou, George A Tanteles, Elena Kkolou, et al.
Southern Medical Journal|June 27, 2008
Special report on the 2007 Pediatric Position Development Conference of the International Society for Clinical DensitometryCatherine M Gordon, Sanford Baim, Maria-Luisa Bianchi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 14, 2009
The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophyRichard C Henderson, Lisa M Berglund, Ryan May, et al.
Bone|December 28, 2020
Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type VMichael P Whyte, James Aronson, William H McAlister, et al.
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
Molecular Genetics and Metabolism|June 18, 2021
Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?Anna Čechová, Tomáš Honzík, Andrew C Edmondson, et al.
Lancet (London, England)|August 10, 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trialNick Bishop, Silvano Adami, S Faisal Ahmed, et al.
Human Mutation|April 14, 2025
Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDGSander Pajusalu, Mari-Anne Vals, Mercedes Serrano, et al.
Pageof 3